EUVIMEDEUVIMED entdecken
Crossref

Biodegradable Monometallic Manganese Nanoparticles for Multimodal Tumor Therapy

Gang Shu iD, Chenya Wang iD, Zhenxing Sun, Jinbin Pan iD, Cai Zhang iD, Jiaojiao Yu, Xiang Jing iD, Yan Zhou, Zhuang Liu iD, Shao-Kai Sun iD

Advanced Healthcare Materials · 01.11.2026

DOI: 10.1002/adhm.71932 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 01.11.2026. Verfasst von Gang Shu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Nanomedicine Laboratory, National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, Chin…. Die Arbeit nennt 57 Literaturangaben. Gefördert von: Tianjin Municipal Education Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Synergistic therapeutic nanoplatforms are of considerable interest in tumor therapy, but their translational potential is often limited by complex multicomponent designs and unknown in vivo degradation behavior. Herein, we show a degradable, single‐component manganese nanoparticles (Mn NPs) using liquid‐phase exfoliation of commercial bulk manganese powder for cancer therapy. In the acidic tumor environment, Mn NPs react with H + to generate Mn 2+ and H 2 and raise the local pH. The released Mn 2+ drives Fenton‐like reactions to produce ROS, while H 2 causes mitochondrial damage, which together lead to tumor cell death. In addition, Mn 2+ activates cGAS‐STING signaling and initiates antitumor immunity. Moreover, Mn NPs inhibit tumor growth in CT26, 4T1, and B16F10 mouse models and show better effects than Mn 2+ alone. Transcriptomic analysis further reveals activation of multiple immune‐related signaling pathways following Mn NP treatment. In a bilateral tumor model, unilateral injection of Mn NPs triggers a systemic antitumor immune response, leading to effective inhibition of distant, untreated tumor growth. Collectively, this study identifies Mn NPs as a simple, biodegradable, single‐component nanoplatform that offers a promising new route for multimodal tumor therapy.

Schlagwörter

Stichwörter der Autor:innen

Mn nanoparticlesantitumor immunitycGAS‐STING pathwayfenton‐like reactionsingle‐metal

Autor:innen und Institutionen

  • Cancer Nanomedicine Laboratory, National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.
  • Department of Radiology, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University Cancer Institute and Hosp…
  • Institute of Functional Nano & Soft Materials (FUNSOM), Biomedical Basic Research Center (BBRC) of Jiangsu Province, Soochow University, Suzhou, China.
  • InnoBM Pharmaceuticals Co. Ltd., Suzhou, Jiangsu, China.
  • School of Medical Imaging, Division of Medical Technology, Tianjin Key Laboratory of Functional Imaging, Tianjin Medical University, Tianjin, China.
  • Department of Radiology, Tianjin Key Laboratory of Functional Imaging, Tianjin Medical University General Hospital, Tianjin, China.

ORCID-Profile: Gang Shu, Chenya Wang, Jinbin Pan, Cai Zhang, Xiang Jing, Zhuang Liu, Shao-Kai Sun

Förderung

  • Tianjin Municipal Education Commission

Zitieren

APA

Shu, G., Wang, C., Sun, Z., Pan, J., Zhang, C., Yu, J., Jing, X., Zhou, Y., Liu, Z., & Sun, S. K. (2026). Biodegradable Monometallic Manganese Nanoparticles for Multimodal Tumor Therapy. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.71932

Vancouver

Shu G, Wang C, Sun Z, Pan J, Zhang C, Yu J, et al. Biodegradable Monometallic Manganese Nanoparticles for Multimodal Tumor Therapy. Advanced Healthcare Materials. 2026. doi:10.1002/adhm.71932

BibTeX
@article{Shu2026,
  author = {Shu, Gang and Wang, Chenya and Sun, Zhenxing and Pan, Jinbin and Zhang, Cai and Yu, Jiaojiao and Jing, Xiang and Zhou, Yan and Liu, Zhuang and Sun, Shao-Kai},
  title = {Biodegradable Monometallic Manganese Nanoparticles for Multimodal Tumor Therapy},
  journal = {Advanced Healthcare Materials},
  year = {2026},
  doi = {10.1002/adhm.71932}
}
Kostenlos starten →